A bit of a catch-22 situation this PHII trial......
1..There aren't enough patients, n=36, to give anything other than "encouraging" data....
2..Given the targeted patients previous nonresponse to treatments it's not surprising
Immutep took a cautious approach re enrolments...
Looks very promising.....
A bit of a catch-22 situation this PHII trial......1..There...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $479.3M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.5¢ | $1.048M | 3.142M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 141492 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 548994 | 21 |
View Market Depth
| Last trade - 15.58pm 27/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |